Detalhe da pesquisa
1.
SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.
Am J Pathol
; 193(4): 456-473, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657718
2.
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Cancer Treat Res
; 190: 211-244, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113003
3.
Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor.
J Cell Sci
; 133(14)2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546533
4.
Differences in the microbial profiles of early stage endometrial cancers between Black and White women.
Gynecol Oncol
; 165(2): 248-256, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277280
5.
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
Gynecol Oncol
; 160(2): 568-578, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328126
6.
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue.
J Pathol
; 252(2): 125-137, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619021
7.
High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice.
Am J Pathol
; 188(7): 1510-1516, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684361
8.
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.
J Pathol
; 242(3): 371-383, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444909
9.
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
J Pathol
; 238(3): 389-400, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26356327
10.
SWI/SNF chromatin remodeling complexes and cancer.
Am J Med Genet C Semin Med Genet
; 166C(3): 350-66, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25169151
11.
ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.
PLoS One
; 19(2): e0297741, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358974
12.
NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
Cancer Res Commun
; 4(2): 487-495, 2024 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335300
13.
Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.
Int J Cancer
; 132(12): 2767-77, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23197309
14.
Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia.
Redox Biol
; 67: 102901, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776708
15.
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss.
Nat Commun
; 14(1): 2894, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210563
16.
BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression.
Nucleic Acids Res
; 38(20): 6906-19, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20571081
17.
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
Oncogene
; 41(25): 3423-3432, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577980
18.
BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest.
J Cell Physiol
; 226(8): 1989-97, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520050
19.
A cytoskeletal function for PBRM1 reading methylated microtubules.
Sci Adv
; 7(14)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811077
20.
Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.
Mol Cancer Res
; 18(12): 1777-1788, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855269